Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules

Background: In Taiwan, the age group with the greatest incidence of invasive pneumococcal disease is 2–5 years of age, which is different from other countries. This study was conducted to identify risk factors and different 13-valent pneumococcal conjugate vaccine (PCV13) schedules associated with v...

Full description

Bibliographic Details
Main Authors: Hong-Yi Lee, Yu-Chia Hsieh, Ching-Chuan Liu, Yi-Chuan Huang, Kuang-Yi Chang, Hsin Chi, Luan-Yin Chang, Yhu-Chering Huang, Li-Min Huang
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Journal of Microbiology, Immunology and Infection
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118217302050
_version_ 1811295009025032192
author Hong-Yi Lee
Yu-Chia Hsieh
Ching-Chuan Liu
Yi-Chuan Huang
Kuang-Yi Chang
Hsin Chi
Luan-Yin Chang
Yhu-Chering Huang
Li-Min Huang
author_facet Hong-Yi Lee
Yu-Chia Hsieh
Ching-Chuan Liu
Yi-Chuan Huang
Kuang-Yi Chang
Hsin Chi
Luan-Yin Chang
Yhu-Chering Huang
Li-Min Huang
author_sort Hong-Yi Lee
collection DOAJ
description Background: In Taiwan, the age group with the greatest incidence of invasive pneumococcal disease is 2–5 years of age, which is different from other countries. This study was conducted to identify risk factors and different 13-valent pneumococcal conjugate vaccine (PCV13) schedules associated with vaccine-type invasive pneumococcal pneumonia (IPP) despite prior vaccination. Methods: A case–control study was conducted prospectively between August 2012 and December 2015 at five participating medical centers. The study enrolled children <15 years of age who were admitted to one of the five medical centers for CAP. Blood samples and acute-phase serum specimens were collected and Streptococcus pneumoniae was identified by using a real-time polymerase-chain-reaction (RT-PCR) assay targeting the lytA gene. Results: A total of 25 children diagnosed with vaccine-type IPP and 124 controls were enrolled. Vaccine-type IPP occurred in 6 (28.6%), 14 (24.1%), and 5 (7.1%) children receiving vaccines on a not-age-appropriate schedule (n = 21), primary infant schedule (n = 58), and toddler catch-up schedule (n = 70) (P = 0.008), respectively. Of 25 children, the mean age at disease onset was 36 ± 11 months; serotype 19A was responsible for 84% (21/25). Conclusion: After adjustment for confounding factors, the risk of vaccine-type IPP was significantly higher among children receiving vaccines on a not-age-appropriate schedule, or on a primary infant schedule, compared with children receiving vaccines on a toddler catch-up schedule. Duration of vaccine immunity should be investigated to direct strategies for maintaining individual and population immunity against pneumococcal disease. Keywords: 13-Valent conjugate pneumococcal vaccine, Invasive pneumococcal pneumonia, Vaccine schedule
first_indexed 2024-04-13T05:26:59Z
format Article
id doaj.art-cf02a738dab84928b3eae5ec65b8829f
institution Directory Open Access Journal
issn 1684-1182
language English
last_indexed 2024-04-13T05:26:59Z
publishDate 2018-04-01
publisher Elsevier
record_format Article
series Journal of Microbiology, Immunology and Infection
spelling doaj.art-cf02a738dab84928b3eae5ec65b8829f2022-12-22T03:00:34ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822018-04-01512199206Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedulesHong-Yi Lee0Yu-Chia Hsieh1Ching-Chuan Liu2Yi-Chuan Huang3Kuang-Yi Chang4Hsin Chi5Luan-Yin Chang6Yhu-Chering Huang7Li-Min Huang8Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung Memorial Hospital, Taoyuan, TaiwanDepartment of Pediatrics, Chang Gung Children's Hospital, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Chang Gung University, College of Medicine, Taoyuan, Taiwan; Corresponding author. Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Children's Hospital, 5 Fu-Hsin Street, Kwei-Shan Hsiang, Taoyuan County, Taiwan. Fax: +886-3-3288957.Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Biostatistics, Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan; Department of Anesthesiology, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, TaiwanDepartment of Pediatrics, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Pediatrics, National Taiwan University Hospital, Taipei, TaiwanDepartment of Pediatrics, Chang Gung Children's Hospital, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Chang Gung University, College of Medicine, Taoyuan, TaiwanDepartment of Pediatrics, National Taiwan University Hospital, Taipei, TaiwanBackground: In Taiwan, the age group with the greatest incidence of invasive pneumococcal disease is 2–5 years of age, which is different from other countries. This study was conducted to identify risk factors and different 13-valent pneumococcal conjugate vaccine (PCV13) schedules associated with vaccine-type invasive pneumococcal pneumonia (IPP) despite prior vaccination. Methods: A case–control study was conducted prospectively between August 2012 and December 2015 at five participating medical centers. The study enrolled children <15 years of age who were admitted to one of the five medical centers for CAP. Blood samples and acute-phase serum specimens were collected and Streptococcus pneumoniae was identified by using a real-time polymerase-chain-reaction (RT-PCR) assay targeting the lytA gene. Results: A total of 25 children diagnosed with vaccine-type IPP and 124 controls were enrolled. Vaccine-type IPP occurred in 6 (28.6%), 14 (24.1%), and 5 (7.1%) children receiving vaccines on a not-age-appropriate schedule (n = 21), primary infant schedule (n = 58), and toddler catch-up schedule (n = 70) (P = 0.008), respectively. Of 25 children, the mean age at disease onset was 36 ± 11 months; serotype 19A was responsible for 84% (21/25). Conclusion: After adjustment for confounding factors, the risk of vaccine-type IPP was significantly higher among children receiving vaccines on a not-age-appropriate schedule, or on a primary infant schedule, compared with children receiving vaccines on a toddler catch-up schedule. Duration of vaccine immunity should be investigated to direct strategies for maintaining individual and population immunity against pneumococcal disease. Keywords: 13-Valent conjugate pneumococcal vaccine, Invasive pneumococcal pneumonia, Vaccine schedulehttp://www.sciencedirect.com/science/article/pii/S1684118217302050
spellingShingle Hong-Yi Lee
Yu-Chia Hsieh
Ching-Chuan Liu
Yi-Chuan Huang
Kuang-Yi Chang
Hsin Chi
Luan-Yin Chang
Yhu-Chering Huang
Li-Min Huang
Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
Journal of Microbiology, Immunology and Infection
title Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
title_full Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
title_fullStr Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
title_full_unstemmed Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
title_short Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
title_sort invasive pneumococcal pneumonia caused by 13 valent pneumococcal conjugate vaccine types in children with different schedules
url http://www.sciencedirect.com/science/article/pii/S1684118217302050
work_keys_str_mv AT hongyilee invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT yuchiahsieh invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT chingchuanliu invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT yichuanhuang invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT kuangyichang invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT hsinchi invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT luanyinchang invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT yhucheringhuang invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules
AT liminhuang invasivepneumococcalpneumoniacausedby13valentpneumococcalconjugatevaccinetypesinchildrenwithdifferentschedules